106 related articles for article (PubMed ID: 1387693)
1. Effects of an IL-1 receptor antagonist on acute myeloid leukemia cells.
Yin M; Gopal V; Banavali S; Gartside P; Preisler H
Leukemia; 1992 Sep; 6(9):898-901. PubMed ID: 1387693
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors.
Estrov Z; Kurzrock R; Estey E; Wetzler M; Ferrajoli A; Harris D; Blake M; Gutterman JU; Talpaz M
Blood; 1992 Apr; 79(8):1938-45. PubMed ID: 1373331
[TBL] [Abstract][Full Text] [Related]
3. Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells.
Rambaldi A; Torcia M; Bettoni S; Vannier E; Barbui T; Shaw AR; Dinarello CA; Cozzolino F
Blood; 1991 Dec; 78(12):3248-53. PubMed ID: 1835893
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cell proliferation and cytokine production in AML by recombinant interleukin-1 receptor antagonist.
Rambaldi A; Torcia M; Dinarello CA; Barbui T; Cozzolino F
Leukemia; 1993 Aug; 7 Suppl 2():S10-2. PubMed ID: 8361209
[TBL] [Abstract][Full Text] [Related]
5. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
[TBL] [Abstract][Full Text] [Related]
6. [Role of peptide regulatory factors in the proliferation of leukemic blasts].
Tabilio A; Falzetti F; Mannoni P; Martelli MF
Haematologica; 1991 Jun; 76 Suppl 3():85-92. PubMed ID: 1752546
[No Abstract] [Full Text] [Related]
7. Modulation of acute myeloblastic leukemia (AML) cell proliferation and blast colony formation by antisense oligomer for IL-1 beta converting enzyme (ICE) and IL-1 receptor antagonist (IL-1ra).
Stosić-Grujicić S; Basara N; Milenković P; Dinarello CA
J Chemother; 1995 Feb; 7(1):67-70. PubMed ID: 7629564
[TBL] [Abstract][Full Text] [Related]
8. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
te Boekhorst PA; Löwenberg B; Vlastuin M; Sonneveld P
Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of IL-1 regulated and spontaneous growth of acute myeloid leukemia in vitro.
Delwel R; Schipper P; van Buitenen C; van Agthoven T; Touw I; Löwenberg B
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():22-6. PubMed ID: 2390638
[No Abstract] [Full Text] [Related]
10. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
Tafuri A; De Felice L; Mascolo MG; Valentini T; Petrucci MT; Petti MC
Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
[TBL] [Abstract][Full Text] [Related]
11. Cellular dynamics of leukemias.
Raza A; Preisler HD
Crit Rev Oncog; 1990; 1(4):373-88. PubMed ID: 2083288
[No Abstract] [Full Text] [Related]
12. Role of suramin as an IL-1 inhibitor in suppression of acute myelogenous leukemia progenitor proliferation.
Estrov Z; Talpaz M; Estey EH; Strassmann G
Exp Hematol; 1995 Sep; 23(10):1080-7. PubMed ID: 7544738
[TBL] [Abstract][Full Text] [Related]
13. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
te Boekhorst PA; Löwenberg B; Sonneveld P
Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in acute myeloblastic leukemia.
McCulloch EA; Kelleher CA; Miyauchi J; Wang C; Cheng GY; Minden MD; Curtis JE
Leukemia; 1988 Dec; 2(12 Suppl):38S-49S. PubMed ID: 3199879
[TBL] [Abstract][Full Text] [Related]
16. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
17. Leukemic hematopoiesis in vitro: acute myeloid leukemia.
Löwenberg B; Touw I
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():5-8. PubMed ID: 2653517
[No Abstract] [Full Text] [Related]
18. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
19. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
20. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
